We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.12%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$284B
AUM Growth
-$3.39B
(-1.2%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
25.31%
Holding
3,279
New
74
Increased
1,024
Reduced
1,721
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$580M |
| 2 |
Intel
INTC
|
+$382M |
| 3 |
Zoetis
ZTS
|
+$256M |
| 4 |
Philip Morris
PM
|
+$225M |
| 5 |
Honeywell
HON
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$562M |
| 2 |
RTX Corp
RTX
|
+$425M |
| 3 |
Apple
AAPL
|
+$365M |
| 4 |
Union Pacific
UNP
|
+$312M |
| 5 |
Microsoft
MSFT
|
+$254M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.53% |
| 2 | Healthcare | 12.08% |
| 3 | Financials | 11.17% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
TG Therapeutics
TGTX
$7.62B
| $3.19M | ﹤0.01% |
382,110
-2,030
| -0.5% | -$28.3K |
|
|
ESTE
2052
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $3.19M | ﹤0.01% |
+157,406
| New | +$2.74M |
|
|
FLNA
2053
Filana Therapeutics
FLNA
$48.1M
| $3.18M | ﹤0.01% |
190,871
-48,852
| -20% | -$968K |
|
2054
Ocular Therapeutix
OCUL
$2.02B
| $3.17M | ﹤0.01% |
1,011,038
+91,436
| +10% | +$374K |
|
|
LAZR
2055
DELISTED
Luminar Technologies
LAZR
| $3.17M | ﹤0.01% |
46,461
-276
| -0.6% | -$25.3K |
|
2056
Lennar Class B
LEN.B
$20.8B
| $3.16M | ﹤0.01% |
32,553
-10,339
| -24% | -$1.08M |
|
|
CHS
2057
DELISTED
Chicos FAS, Inc.
CHS
| $3.16M | ﹤0.01% |
422,278
+11,914
| +3% | +$64K |
|
|
AVTA
2058
DELISTED
Avantax, Inc. Common Stock
AVTA
| $3.15M | ﹤0.01% |
123,300
-4,823
| -4% | -$114K |
|
2059
Aclaris Therapeutics
ACRS
$869M
| $3.15M | ﹤0.01% |
460,313
+258,896
| +129% | +$2.21M |
|
2060
Kaiser Aluminum
KALU
$3.02B
| $3.15M | ﹤0.01% |
41,849
-56
| -0.1% | -$4.25K |
|
2061
Dell
DELL
$293B
| $3.14M | ﹤0.01% |
45,600
| – | – |
|
2062
Pennant Group
PNTG
$1.36B
| $3.14M | ﹤0.01% |
282,161
-16,130
| -5% | -$187K |
|
2063
IES Holdings
IESC
$15.2B
| $3.14M | ﹤0.01% |
47,626
+9,344
| +24% | +$608K |
|
2064
Viridian Therapeutics
VRDN
$2.67B
| $3.12M | ﹤0.01% |
203,441
-222,754
| -52% | -$4.25M |
|
|
TWO
2065
Two Harbors Investment
TWO
$1.27B
| $3.12M | ﹤0.01% |
235,503
-4,461
| -2% | -$59.8K |
|
2066
PC Connection
CNXN
$2.12B
| $3.12M | ﹤0.01% |
58,369
-8,577
| -13% | -$436K |
|
2067
Rocket Pharmaceuticals
RCKT
$394M
| $3.11M | ﹤0.01% |
151,681
-2,764
| -2% | -$50.2K |
|
|
PRA
2068
DELISTED
ProAssurance
PRA
| $3.11M | ﹤0.01% |
164,516
-1,836
| -1% | -$31.8K |
|
2069
Geron
GERN
$949M
| $3.11M | ﹤0.01% |
1,465,714
+94,739
| +7% | +$257K |
|
|
PMT
2070
PennyMac Mortgage Investment
PMT
$842M
| $3.1M | ﹤0.01% |
249,729
-2,789
| -1% | -$36.5K |
|
|
FSR
2071
DELISTED
Fisker Inc.
FSR
| $3.08M | ﹤0.01% |
480,433
+717
| +0.1% | +$4.36K |
|
|
CPRX
2072
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.08M | ﹤0.01% |
263,835
+4,631
| +2% | +$61.9K |
|
|
MTTR
2073
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $3.06M | ﹤0.01% |
1,408,923
+496,739
| +54% | +$1.39M |
|
2074
Microvision
MVIS
$78.9M
| $3.05M | ﹤0.01% |
92,973
-646
| -0.7% | -$29.6K |
|
2075
Levi Strauss
LEVI
$9.39B
| $3.04M | ﹤0.01% |
224,179
-3,202
| -1% | -$44.8K |
|
Similar funds
VFT
Nuveen's Q3 2023 Portfolio in Review
As of Q3 2023, Nuveen held 3,279 positions worth $284B, down 1.2% from $287B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.5%. Nuveen opened 74 new positions and exited 74, leaving the 3,279-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2023 buy was Primo Water Corporation: 4,446,437 shares worth $61.4M.
- Nuveen added most to Kenvue in Q3 2023, an estimated $580M increase.
- Nuveen's biggest Q3 2023 reduction was PepsiCo, cutting an estimated $562M.
- Nuveen fully exited Life Storage, Inc. in Q3 2023, selling an estimated $77.3M.
- Nuveen's ten largest holdings make up 25% of its $284B portfolio in Q3 2023.
- Nuveen opened 74 new positions and closed 74 in Q3 2023.
- Nuveen's portfolio value fell 1.2% quarter-over-quarter to $284B.
Based on Nuveen's 13F filing for Q3 2023, filed 14 Nov 2023.